Archive: https://archive.today/7I4uj From the post: >>Mounjaro could help slash the risk of breast cancer tumours developing, exciting new research has suggested. The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits, such as reducing the risk of heart attacks, strokes and kidney disease. Now, scientists have discovered that tirzepatide—the ingredient behind Mounjaro—may 'significantly' slow the growth of breast cancer tumours. American scientists, who carried out the trial, said the findings on mice show the drugs have a 'beneficial impact' on women with the disease.